Startups
Edit
BiondVax Pharmaceuticals Ltd.
http://www.biondvax.com/Last activity: 17.04.2023
Probably Closed - Reference to Scinai Immunotherapeutics Ltd.
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, m
Overview
Employees
11-50
Phone
+972 8-930-2529
Total raised
$39.28M
Founded date
2003
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Sep 18, 2017 | Funding round | $10M | |
| Jun 20, 2017 | Funding round | $22.33M |
Mentions in press and media 29
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 30, 2022 | BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update | /EIN News/ -- JERUSALEM, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for ... |
| Dec 28, 2021 | Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors | JERUSALEM, Dec. 27, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious d... |
| Dec 27, 2021 | Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors | JERUSALEM, Dec. 27, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious d... |
| Nov 30, 2021 | BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update | JERUSALEM, Nov. 30, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illn... |
| Nov 30, 2021 | BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update | JERUSALEM, Nov. 30, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illn... |
| Nov 24, 2021 | BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business Update | JERUSALEM, Israel, Nov. 24, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and ot... |
| Nov 22, 2021 | BiondVax Pharmaceuticals : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K | NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To Be Held on December 27, 2021 The Annual General Meeting of Shareholders of BiondVax Pharmaceuticals Ltd. (the "Company") will be held at the offices of Gross & Co., One Azrie... |
| Oct 19, 2021 | BiondVax Pharmaceuticals : advances its growth strategy towards a new pipeline based on innovative VHH antibodies | JERUSALEM, Oct. 19, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illn... |
| Aug 26, 2021 | BiondVax Announces Second Quarter 2021 Financial Results and Provides Business Update | JERUSALEM, Aug. 26, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious d... |
Show more
Reviews 0
FAQ about BiondVax Pharmaceuticals Ltd.
When was BiondVax Pharmaceuticals Ltd. founded?
BiondVax Pharmaceuticals Ltd. was founded in 2003.
How much funding has BiondVax Pharmaceuticals Ltd. raised?
BiondVax Pharmaceuticals Ltd. has raised $39.28M in total across 3 funding rounds.
What funding rounds has BiondVax Pharmaceuticals Ltd. raised?
Parsers VC lists 3 funding rounds of BiondVax Pharmaceuticals Ltd., among them a funding round of $10M on Sep 18, 2017 and a funding round of $22.33M on Jun 20, 2017.
What has the press written about BiondVax Pharmaceuticals Ltd.?
Parsers VC has collected 29 articles mentioning BiondVax Pharmaceuticals Ltd., among them “BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update” (Nov 30, 2022) and “Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors” (Dec 28, 2021).
Is BiondVax Pharmaceuticals Ltd. still active?
BiondVax Pharmaceuticals Ltd. is probably closed: its latest activity on Parsers VC dates from Apr 17, 2023.